Abstract
Background
Right heart catheterization (RHC) is important in the evaluation of pulmonary hypertension, but is not without risk.
Hypothesis
We wished to assess the safety, efficacy, and tolerability of RHC performed via the internal jugular vein (IJV) at our tertiary cardiothoracic center.
Methods
A retrospective review of the medical records for all patients undergoing RHC via the IJV between January 1, 2007 and July 31, 2009 was performed. We do not routinely use ultrasound guidance or stop anticoagulation. Operators with a median experience of 450 procedures performed the RHCs.
Results
Right heart catheterization was performed on 349 patients with a median age of 66 years (range, 17–89), median mean pulmonary artery pressure of 30 mm Hg (range, 8–69), and a median internationalized normal ratio of 2.5. Of 349 patients, we were unable to obtain intravenous access in only 1 patient; 342 (98%) patients tolerated RHC with local anesthetic alone; and 6 patients required additional sedation with benzodiazepines. The median time for the procedure was 15 minutes. Complications occurred in 6 patients (1.7%) and included carotid puncture (n = 3), sinus bradycardia below 45 beats/min, which responded promptly to atropine and intravenous fluid (n = 2), and complete heart block without hemodynamic compromise (n = 1). There were no pneumothoraxes, pulmonary hemorrhage, or deaths related to the procedure.
Conclusion
Right heart catheterization via the IJV is quick, safe, and well tolerated. It is not associated with an increased risk of pneumothorax or other complications when performed by experienced operators. Copyright © 2010 Wiley Periodicals, Inc.
Full Text
The Full Text of this article is available as a PDF (107.6 KB).
References
- 1. Thenappan T, Shah SJ, Rich S, Gomberg‐Maitland M. A USA‐based registry for pulmonary arterial hypertension: 1982–2006. Eur Respir J 2007; 30: 1103–1110. [DOI] [PubMed] [Google Scholar]
- 2. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009; 53: 1573–1619. [DOI] [PubMed] [Google Scholar]
- 3. Hadian M, Pinsky MR. Evidence‐based review of the use of the pulmonary artery catheter: impact data and complications. Crit Care 2006; 10(suppl 3): S8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Harvey S, Harrison DA, Singer M, et al. Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC‐Man): a randomised controlled trial. Lancet 2005; 366: 472–477. [DOI] [PubMed] [Google Scholar]
- 5. Binanay C, Califf RM, Hasselblad V, et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 2005; 294: 1625–1633. [DOI] [PubMed] [Google Scholar]
- 6. Hoeper MM, Lee SH, Voswinckel R, et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol 2006; 48: 2546–2552. [DOI] [PubMed] [Google Scholar]
- 7. Parienti JJ, Thirion M, Megarbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 2008; 299: 2413–2422. [DOI] [PubMed] [Google Scholar]
- 8. Karakitsos D, Labropoulos N, De Groot E, et al. Real‐time ultrasound‐guided catheterization of the internal jugular vein: a prospective comparison with the landmark technique in critical care patients. Crit Care 2006; 10: R162. [DOI] [PMC free article] [PubMed] [Google Scholar]